z-logo
open-access-imgOpen Access
Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats
Author(s) -
Dan Liang,
Zhanrong Li,
Yao Lin,
Jingguo Li,
Zhang,
Xianghua Wu,
Yi Liu,
Miaoli Lin,
Wenru Su,
Yongping Li
Publication year - 2012
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s27860
Subject(s) - celastrol , corneal neovascularization , chemistry , angiogenesis , umbilical vein , cornea , vascular endothelial growth factor , neovascularization , microbiology and biotechnology , biophysics , materials science , biochemistry , medicine , in vitro , apoptosis , biology , cancer research , ophthalmology , vegf receptors
Celastrol, a traditional Chinese medicine, is widely used in anti-inflammation and anti-angiogenesis research. However, the poor water solubility of celastrol restricts its further application. This paper aims to study the effect of celastrol nanoparticles (CNPs) on corneal neovascularization (CNV) and determine the possible mechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom